D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZUN
1851
Baozun
BZUN
$168M
| $5.65M | 0.01% |
322,189
+232,361
| +259% | +$5.71M |
|
1852
CALL
Rapid7
RPD
$642M
| $5.64M | 0.01% |
49,900
+30,000
| +151% | +$3.4M |
|
1853
CALL
SLB Ltd
SLB
$74.2B
| $5.63M | 0.01% |
190,000
+100,000
| +111% | +$2.87M |
|
|
KRNL
1854
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $5.63M | 0.01% |
577,754
+261,155
| +82% | +$2.53M |
|
1855
PUT
Paychex
PAYX
$42.3B
| $5.62M | 0.01% |
+50,000
| New | +$5.62M |
|
1856
PUT
Globant
GLOB
$1.52B
| $5.62M | 0.01% |
+20,000
| New | +$5.49M |
|
1857
New Oriental
EDU
$8.08B
| $5.61M | 0.01% |
273,544
+238,940
| +690% | +$7.59M |
|
1858
CenterPoint Energy
CNP
$28.8B
| $5.61M | 0.01% |
227,853
-98,642
| -30% | -$2.52M |
|
|
SGEN
1859
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.6M | 0.01% |
33,000
| – | – |
|
1860
CALL
CRISPR Therapeutics
CRSP
$4.68B
| $5.6M | 0.01% |
50,000
+10,000
| +25% | +$1.26M |
|
1861
Humana
HUM
$46.7B
| $5.6M | 0.01% |
14,378
-6,669
| -32% | -$2.83M |
|
|
NGC
1862
DELISTED
Northern Genesis Acquisition Corp. III
NGC
| $5.59M | 0.01% |
576,241
+351,026
| +156% | +$3.43M |
|
1863
CALL
Gilead Sciences
GILD
$167B
| $5.59M | 0.01% |
80,000
-255,600
| -76% | -$18M |
|
|
ANAC
1864
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $5.58M | 0.01% |
572,527
+518,679
| +963% | +$5.04M |
|
1865
PUT
Rocket Companies
RKT
$39.6B
| $5.58M | 0.01% |
347,800
+97,800
| +39% | +$1.71M |
|
|
RMGC
1866
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $5.58M | 0.01% |
573,385
+323,385
| +129% | +$3.14M |
|
1867
CBRE Group
CBRE
$43.1B
| $5.58M | 0.01% |
+57,286
| New | +$5.32M |
|
1868
Sana Biotechnology
SANA
$916M
| $5.58M | 0.01% |
+247,589
| New | +$5.2M |
|
1869
PUT
Hilton Worldwide
HLT
$73.4B
| $5.58M | 0.01% |
42,200
-7,800
| -16% | -$986K |
|
1870
CALL
Waters Corp
WAT
$37.7B
| $5.57M | 0.01% |
15,600
+14,000
| +875% | +$5.48M |
|
1871
PUT
Bio-Techne
TECH
$11.2B
| $5.57M | 0.01% |
46,000
-40,000
| -47% | -$4.87M |
|
1872
Moelis & Co
MC
$5.1B
| $5.57M | 0.01% |
89,975
-54,430
| -38% | -$3.26M |
|
1873
GrowGeneration
GRWG
$88.3M
| $5.56M | 0.01% |
225,449
+209,726
| +1,334% | +$7.41M |
|
1874
DigitalOcean
DOCN
$13.2B
| $5.56M | 0.01% |
71,588
+9,727
| +16% | +$601K |
|
1875
Autoliv
ALV
$9.09B
| $5.54M | 0.01% |
64,654
-26,398
| -29% | -$2.44M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.